AMGEN ANNOUNCES WEBCAST OF 2026 FIRST QUARTER FINANCIAL RESULTS
Rhea-AI Summary
Amgen (NASDAQ:AMGN) will report first quarter 2026 financial results on Thursday, April 30, 2026, after the U.S. market close. A conference call with management, including CEO Robert A. Bradway, will follow at 4:30 p.m. ET.
Live audio will be webcast on Amgen's investor site and archived for at least 90 days. Presentation times and webcast links are listed on Amgen's Investor Relations Events Calendar.
Positive
- None.
Negative
- None.
News Market Reaction – AMGN
In the Apr 27 session, AMGN declined 1.27%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 03 | Earnings report | Positive | +8.2% | Strong FY 2025 revenue, EPS growth and cash flow with mixed product trends. |
| Jan 28 | Earnings webcast | Neutral | +0.2% | Announcement of Q4 2025 and full-year 2025 results webcast and timing. |
| Nov 04 | Earnings report | Positive | +7.8% | Q3 2025 revenue and EPS growth with improved GAAP margin and debt reduction. |
| Oct 29 | Earnings webcast | Neutral | +0.1% | Scheduling of Q3 2025 results release and investor webcast details. |
| Aug 05 | Earnings report | Positive | -5.1% | Q2 2025 revenue and EPS growth with strength in key growth products. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings reports with solid growth have often seen strong positive reactions, while webcast scheduling releases have historically coincided with only modest moves.
Recent earnings-related news for Amgen shows a pattern of strong fundamental performance and generally positive price reactions. Q2 and Q3 2025 results highlighted solid revenue and EPS growth, with notable gains following Q3 2025 and full-year 2025 reports. In contrast, prior “webcast of results” announcements on Aug 5, 2025 and Oct 29, 2025 were associated with relatively small next-day moves. Today’s Q1 2026 webcast notice fits into this cadence of regular quarterly reporting communication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines.
More than 45 years ago, Amgen helped establish the biotechnology industry at its
Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube, Facebook, TikTok and Threads.
CONTACT: Amgen,
Elissa Snook, 609-251-1407 (media)
Casey Capparelli, 805-447-1746 (investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2026-first-quarter-financial-results-302753310.html
SOURCE Amgen